Write a IAP and NELSON based essay for my MD PEDIATRIC THEORY Exam on topic Acute phase reactants

Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Reading File
Finding Sources
Reading File
Searching the Web

IAP guidelines acute phase reactants CRP ESR procalcitonin pediatric 2024


ACUTE PHASE REACTANTS

MD Pediatrics Theory Examination Essay


INTRODUCTION

Acute phase reactants (APRs) are a heterogeneous group of plasma proteins whose concentrations change by at least 25% from baseline in response to inflammatory stimuli, including infection, trauma, surgery, malignancy, autoimmune disorders, and tissue necrosis. The term "acute phase response" refers to the systemic inflammatory reaction that accompanies tissue injury, representing the body's attempt to restore homeostasis. Within minutes of tissue injury, activation of the innate immune system induces cytokine production that results in a multisystem response involving the liver, vascular system, bone marrow, and central nervous system. (Firestein & Kelley's Textbook of Rheumatology)
In pediatric practice, APRs serve three primary clinical roles:
  1. Assessing the extent and severity of an inflammatory process
  2. Monitoring disease activity over time with serial measurements
  3. Providing prognostic information

PATHOPHYSIOLOGY AND MECHANISM

Cytokine Cascade

The acute phase response is orchestrated by cytokines released from activated monocytes, macrophages, neutrophils, natural killer cells, and endothelial cells at sites of injury or infection. The principal cytokine is interleukin-6 (IL-6), once called the hepatocyte-stimulating factor. IL-6 regulates hepatic protein expression via the JAK/STAT3 pathway as well as C/EBP family members and NF-kB.
During initial stages, IL-1 and TNF-alpha synergize with IL-6 and trigger further IL-6 production. IL-6, via transsignaling (binding to soluble IL-6R), activates the coreceptor gp130 to amplify local and systemic effects. IL-6 also has a protective role, inducing IL-1 receptor antagonist expression.
Other cytokines involved include:
  • Interleukin-1 (IL-1)
  • Tumor necrosis factor-alpha (TNF-alpha)
  • Interferon-gamma (IFN-gamma)
The total physiological response includes:
  • Induction of fever
  • Leukocyte recruitment
  • Muscle catabolism
  • Shift in hepatic protein synthesis (increased APRs, decreased albumin, transferrin)
(Henry's Clinical Diagnosis and Management by Laboratory Methods; Firestein & Kelley's Textbook of Rheumatology)

CLASSIFICATION OF ACUTE PHASE PROTEINS

A. Positive Acute Phase Reactants (Increase in Inflammation)

These proteins increase in concentration during inflammation. They are categorized by magnitude of rise:
CategoryMagnitude of RiseExamples
Major APRs> 1000-foldC-reactive protein (CRP), Serum Amyloid A (SAA)
Moderate APRs2-4 foldFibrinogen, Haptoglobin, alpha-1-proteinase inhibitor, alpha-1-acid glycoprotein
Minor APRs50-100%Complement components (C3, C4, C9), Ceruloplasmin
Complete list of positive APRs includes:
  • Complement system: C3, C4, C9, Factor B, C1 inhibitor, C4b-binding protein, Mannose-binding lectin
  • Coagulation/fibrinolytic system: Fibrinogen, Plasminogen, tPA, Urokinase, Plasminogen-activator inhibitor-1
  • Anti-proteases: Alpha-1-protease inhibitor, alpha-anti-chymotrypsin, Inter-alpha-trypsin inhibitors
  • Transport proteins: Ceruloplasmin, Haptoglobin, Hemopexin
  • Mediators of inflammation: Secreted phospholipase A2, Lipopolysaccharide-binding protein (LBP), IL-1 receptor antagonist, G-CSF
  • Others: CRP, Serum Amyloid A, Alpha-1-acid glycoprotein, Fibronectin, Ferritin, Angiotensinogen
(Firestein & Kelley's Textbook of Rheumatology, Table 57.1)

B. Negative Acute Phase Reactants (Decrease in Inflammation)

These proteins fall by at least 25% during the inflammatory response:
  • Albumin (most important clinically)
  • Transferrin
  • Transthyretin (Pre-albumin)
  • Alpha-fetoprotein
  • Thyroxine-binding globulin
  • Insulin-like growth factor I (IGF-I)
  • Anti-thrombin III
  • Protein S
  • Factor XII
  • Apolipoprotein A-I
Clinical significance of negative APRs: Albumin and transferrin drop almost immediately after the onset of inflammation and remain depressed for days. This makes them unreliable as nutritional markers in acute illness. Transferrin, with a half-life of 8 days, may be a slightly better nutritional marker than albumin (half-life 21 days) as it returns to normal faster. (Firestein & Kelley's Textbook of Rheumatology)

INDIVIDUAL ACUTE PHASE REACTANTS

1. C-REACTIVE PROTEIN (CRP)

Structure and Origin: CRP is a pentameric protein belonging to the pentraxin family, synthesized exclusively in the liver under IL-6 stimulation. It was named after its ability to bind the C-polysaccharide of Streptococcus pneumoniae.
Kinetics:
  • Undetectable in health (< 10 mg/L or < 1 mg/dL is normal)
  • Begins to rise within 6-12 hours of the inflammatory stimulus
  • Peaks within 2-3 days
  • Returns to normal rapidly following successful therapy
  • Half-life is approximately 19 hours (short, making it ideal for monitoring)
  • Can rise up to 1000-fold above baseline in severe bacterial infection
Biological Functions:
  1. Activates the classical complement pathway
  2. Opsonization - binds phosphocholine on damaged cell membranes and microbial surfaces
  3. Binds chromatin (important in autoimmunity)
  4. Inhibits neutrophil adhesion to endothelial cells (via L-selectin shedding)
  5. Scavenges cellular debris and directs phagocytic disposal
Clinical Cut-offs in Pediatrics:
CRP LevelInterpretation
< 10 mg/L (< 1 mg/dL)Normal
10-40 mg/LMinor infection, viral illness, post-vaccination
40-200 mg/LModerate bacterial infection
> 200 mg/LSevere bacterial infection, sepsis
2-10 mg/L (high-sensitivity CRP)Subclinical "metabolic inflammation" (cardiovascular risk, obesity)
CRP vs. ESR - Key Differences:
FeatureCRPESR
TypeDirect measurementIndirect measure
Rise after stimulus6-12 hours24-48 hours
Peak2-3 daysDays to weeks
Return to normalDaysWeeks to months
Sensitivity for active inflammationHigherLower
Specificity for bacterial infectionHigherLower
Influenced by anemiaNoYes (falsely high)
Influenced by age/sexMinimalSignificant
Influenced by polycythemiaNoYes (falsely low)
Monitoring disease activityBetterGood (chronic)
Special Pediatric Contexts for CRP:
  • Neonatal sepsis: CRP rises within 12-24 hours; serial values more useful than a single measurement. Normal at birth, rises in early-onset sepsis.
  • Kawasaki disease: Very elevated CRP (often >100 mg/L); persistent elevation after Day 10 suggests incomplete response to IVIG or increased risk of coronary artery aneurysm.
  • JIA/Systemic JIA: Markedly elevated CRP in systemic JIA; CRP in macrophage activation syndrome (MAS) may paradoxically fall while ferritin soars.
  • Febrile neutropenia: CRP > 90 mg/L at 24-48 hours of fever predicts bacteremia.
  • Bacterial vs. viral infection: CRP > 40-80 mg/L strongly favors bacterial etiology.
  • Post-IVIG limitation: IVIG independently raises ESR; CRP is preferred for monitoring after Kawasaki IVIG treatment. (Red Book 2021, AAP)
(Henry's Clinical Diagnosis and Management; Firestein & Kelley's Textbook of Rheumatology)

2. ERYTHROCYTE SEDIMENTATION RATE (ESR)

Principle and Measurement: ESR is an indirect marker of elevated acute phase proteins, not a direct APR itself. When blood is placed in a vertical tube (Westergren method: 200 mm glass tube with 1.6 mm bore), the rate of red blood cell fall in mm/hour is measured.
ESR reflects rouleaux formation - the tendency of RBCs to stack like coins. Rouleaux is enhanced by:
  • Fibrinogen (most important)
  • Globulins (IgG, IgM, IgA)
  • Alpha-2 macroglobulin
  • Decreased albumin
Normal Values (Westergren method):
  • Children: < 10-20 mm/hr (age-dependent)
  • Adult men: < 15 mm/hr (approximate: age/2)
  • Adult women: < 20 mm/hr (approximate: (age+10)/2)
  • ESR physiologically higher in women and increases with age
  • ESR increases during pregnancy
Kinetics:
  • Rises within 24-48 hours of the inflammatory stimulus (slower than CRP)
  • Remains elevated for weeks to months even after resolution (the "lag" effect)
  • This slow normalization makes ESR useful for monitoring chronic inflammatory states but not acute fluctuations.
Factors Causing a Falsely Elevated ESR (non-inflammatory):
  • Anemia (decreased hematocrit allows faster fall)
  • Obesity
  • Hypercholesterolemia
  • Female sex, older age
  • Renal insufficiency
  • Technical: tilted tube, prolonged standing, high room temperature
Factors Causing a Falsely Low ESR:
  • Polycythemia, sickle cell disease (abnormal RBC shape)
  • Chronic lymphocytic leukemia
  • Congestive heart failure
  • Extreme leukocytosis
  • Hypofibrinogenemia
  • Technical: short tube, air bubbles, low temperature
Clinical Significance in Pediatrics:
  • ESR > 100 mm/hr strongly suggests: bacterial infection, malignancy (especially leukemia/lymphoma), autoimmune disease, or inflammatory bowel disease.
  • JIA monitoring: ESR is a component of the JADAS (Juvenile Arthritis Disease Activity Score).
  • Kawasaki disease: ESR elevated in acute phase; after IVIG, ESR may be unreliable (use CRP instead).
  • Osteomyelitis/Septic arthritis: ESR rises within 2-3 days, remains elevated for weeks. Normalizes slower than CRP.
  • Tubeculous disease: ESR often markedly elevated (> 60 mm/hr); useful for monitoring treatment response over months.
  • Nephrotic syndrome: Elevated due to hyperfibrinogenemia and hypoalbuminemia.

3. PROCALCITONIN (PCT)

Origin and Structure: PCT is the precursor peptide of calcitonin. In healthy individuals, it is produced by thyroid C-cells and is rapidly cleaved; serum levels remain very low (< 0.05 ng/mL). During bacterial infection, extra-thyroidal production of PCT occurs in virtually all parenchymal tissues and circulating monocytes, stimulated by IL-1, IL-6, and TNF-alpha.
Key Feature: In viral infections, interferon-gamma (IFN-gamma) produced by activated T cells downregulates PCT synthesis - this is the basis of its specificity for bacterial over viral infection.
Kinetics:
  • Detectable within 3-4 hours of bacterial stimulus (faster than CRP)
  • Peaks within 6-24 hours
  • Half-life: 25-30 hours
  • Normal: < 0.05 ng/mL
PCT Interpretation (Clinical Cut-offs):
PCT LevelInterpretation
< 0.05 ng/mLNormal, healthy
0.05-0.5 ng/mLLow risk of bacterial infection; viral or localized infection likely
0.5-2 ng/mLModerate systemic infection; antibiotics may be considered
2-10 ng/mLSevere systemic infection/sepsis; antibiotics recommended
> 10 ng/mLSevere sepsis/septic shock; urgent antibiotic therapy
Advantages of PCT over CRP in Pediatrics:
  1. Rises faster (3-4 hours vs. 12-24 hours)
  2. More specific for bacterial vs. viral infection
  3. Better for distinguishing sepsis from non-infectious SIRS
  4. More useful for antibiotic stewardship - rising PCT = continue antibiotics; falling PCT = can stop
  5. Not elevated in non-infectious inflammatory states (IBD, polyarteritis nodosa, SLE, gout, polymyalgia rheumatica, temporal arteritis)
Pediatric Applications of PCT:
  • Neonatal sepsis: PCT physiologically elevated in first 48-72 hours of life (normal up to 2-21 ng/mL on Day 1); falls by Day 3. Serial measurements essential.
  • Febrile UTI/Pyelonephritis: PCT > 0.5 ng/mL is associated with high likelihood of pyelonephritis and renal scarring in children with UTI.
  • Meningitis: PCT levels - both serum and CSF - have high diagnostic accuracy for bacterial meningitis.
  • Kawasaki disease: PCT generally low (favors non-bacterial etiology), which helps distinguish from bacterial sepsis.
  • Fever with petechiae: Children presenting with fever and petechiae - PCT > 0.5 ng/mL along with abnormal CRP and WBC increases risk of meningococcal disease. (Rosen's Emergency Medicine)
  • Antibiotic stewardship in PICU: Serial PCT-guided protocols reduce antibiotic duration without adverse outcomes.
Important caveat: In immunosuppressed children (especially those on IL-6 receptor antagonists like tocilizumab), CRP may be falsely normal despite infection; in such cases, PCT may be more informative. (Rheumatology, Elsevier 2022)

4. SERUM AMYLOID A (SAA)

  • An apolipoprotein synthesized by hepatocytes; normal level < 10 mg/L
  • Rises 1000-fold along with CRP during acute infection (peaks Day 2-3)
  • Major role: Mobilizes cholesterol from macrophages and hepatocytes; acts as an opsonin
  • In systemic JIA and MAS (Macrophage Activation Syndrome): SAA is markedly elevated and useful for monitoring disease activity
  • In Familial Mediterranean Fever (FMF): SAA is the amyloidogenic precursor; persistently elevated SAA leads to AA amyloidosis - the main long-term complication. Serial measurement guides colchicine dosing to prevent amyloid deposition.

5. FERRITIN

  • Iron storage protein; also an APR (moderate positive reactant)
  • Normal: 12-150 ng/mL (varies by age and sex)
  • Ferritin as a Pediatric Biomarker:
    • In Systemic JIA: markedly elevated (often > 10,000 ng/mL); a defining feature of systemic JIA
    • In Macrophage Activation Syndrome (MAS): ferritin > 500 ng/mL suggests MAS; levels between 5,000-10,000 ng/mL favor MAS diagnosis. A threshold of 13,405 microg/L optimizes diagnosis of hemophagocytic lymphohistiocytosis (HLH) with sensitivity 76% and specificity 79%.
    • In HLH: ferritin > 10,000 ng/mL (occasionally > 1,00,000 ng/mL)
    • May also occasionally rise > 20,000 ng/mL in other severe inflammatory states
Critical pearl: A ferritin level <= 500 ng/mL does NOT reliably exclude MAS. (Firestein & Kelley's Textbook of Rheumatology)

6. HAPTOGLOBIN

  • Binds free hemoglobin; transports the hemoglobin-haptoglobin complex to hepatocytes for recycling (conserves iron)
  • Rises 2-4 fold as an APR
  • Clinically falls in hemolysis (consumed), making it a marker of hemolytic states
  • Used in neonatal hemolysis evaluation

7. FIBRINOGEN

  • Clotting factor and major APR; rises 2-4 fold
  • Central to ESR elevation (fibrinogen promotes rouleaux formation)
  • In FMF attacks: fibrinogen along with CRP, SAA, ESR, and haptoglobin all rise markedly
  • In Kawasaki disease: hyperfibrinogenemia contributes to thrombotic risk

8. CERULOPLASMIN

  • Copper-transport protein; rises ~50% as an APR
  • Falls in Wilson's disease, protein-losing states, malnutrition
  • Role in inflammation: has ferroxidase activity; may serve as antioxidant

9. COMPLEMENT COMPONENTS (C3, C4)

  • Both are positive APRs; rise in inflammation
  • Important exception in SLE: Despite active inflammation, C3 and C4 are consumed by immune complex deposition, so they may be low or normal. This explains the phenomenon where CRP is also often low/normal in SLE (despite very high ESR) - a key discriminator.
  • The SLE-ESR/CRP dissociation: In active SLE, ESR is markedly elevated while CRP remains normal. This is one of the most important discriminations in rheumatology.

10. ALPHA-1 ACID GLYCOPROTEIN (OROSOMUCOID)

  • Rises 2-4 fold
  • Has immunomodulatory functions; binds basic and neutral lipophilic drugs
  • Can affect drug binding and pharmacokinetics during acute illness

COMPARISON TABLE: CRP vs. ESR vs. PCT

FeatureCRPESRPCT
NatureDirect proteinIndirect measurePeptide prehormone
Normal value< 10 mg/L< 20 mm/hr (children)< 0.05 ng/mL
Time to rise6-12 hours24-48 hours3-4 hours
Peak2-3 daysDays-weeks6-24 hours
Return to normalDaysWeeks-months24-48 hours after resolution
Bacterial vs. viralModerate specificityPoor specificityBest specificity
Max elevation1000x2-3x (indirect)Hundreds-fold
Influenced by anemiaNoYes (high)No
Useful in SLEOften normalVery highNormal
Neonatal interpretationUnreliable in first 24hUnreliable (high at birth)Physiologically high in first 48h
Post-IVIGReliableUnreliable (falsely high)Reliable
Anti-inflammatory drug effectRapidly normalizesSlowly normalizesMay mask if on IL-6 inhibitors

CLINICAL APPLICATIONS IN PEDIATRICS

1. Neonatal Sepsis

  • CRP: Normal at birth; rises in early-onset sepsis after 12-24 hours. A single normal CRP does not exclude sepsis; serial measurements every 12-24 hours improve sensitivity (> 90% when measured at 12 and 24 hours combined).
  • PCT: Physiologically elevated in healthy neonates in first 48-72 hours (up to 21 ng/mL on Day 1 of life). Values beyond this physiological peak, or a secondary rise, are concerning for late-onset sepsis.
  • ESR: Limited value in neonates; blood volume constraints and high neonatal hematocrit affect results.

2. Fever Without Source (FWS) / Serious Bacterial Infection (SBI)

  • CRP > 40-80 mg/L and PCT > 0.5 ng/mL together with ANC and WBC substantially improve sensitivity for detecting SBI in febrile children.
  • The "Lab Score" (combining PCT, CRP, and urinalysis) is used in some centers.
  • CRP alone has sensitivity ~88% and specificity ~75% for bacterial infection.

3. Urinary Tract Infection and Pyelonephritis

  • PCT > 0.5 ng/mL predicts pyelonephritis (upper tract involvement) and future renal scarring in children with UTI.
  • CRP > 20 mg/L suggests upper tract disease.
  • ESR > 30 mm/hr also seen in pyelonephritis.
  • However, ESR, CRP, and PCT alone are not sufficiently accurate to differentiate cystitis from pyelonephritis. (PIDS/PIDSP systematic review)

4. Acute Rheumatic Fever (ARF)

  • Jones Criteria (Modified, WHO): Elevated APRs (CRP > 30 mg/L or ESR > 30 mm/hr) are included as minor criteria.
  • APRs rise in virtually all cases of ARF except in pure chorea or erythema marginatum as sole manifestation - an important exception to know.
  • Serial monitoring of CRP/ESR guides secondary prophylaxis and detection of carditis progression.
  • ESR normalizes by 3 months in uncomplicated ARF. (Firestein & Kelley's Textbook of Rheumatology)

5. Juvenile Idiopathic Arthritis (JIA)

  • Systemic JIA: CRP markedly elevated; ferritin very high; SAA elevated. The degree of ferritin elevation tracks disease activity.
  • Oligoarticular/Polyarticular JIA: CRP and ESR elevated proportional to joint involvement.
  • Macrophage Activation Syndrome (MAS): Paradoxical fall in ESR and CRP despite worsening clinical status, in contrast to soaring ferritin. This "falling CRP with rising ferritin" pattern is a red flag for MAS.
  • JADAS score: Includes ESR as a component.
  • CRP > 20 mg/L and ESR > 20 mm/hr as remission criteria (both must be normal for ACR/EULAR inactive disease definition in JIA).

6. Kawasaki Disease (KD)

  • CRP and ESR markedly elevated in acute phase; CRP often > 100 mg/L.
  • Prolonged CRP elevation after Day 10 of illness suggests incomplete KD or predicts increased coronary artery aneurysm risk.
  • After IVIG treatment: ESR is unreliable (IVIG independently elevates ESR). CRP is preferred for post-treatment monitoring.
  • Platelet count (thrombocytosis, typically > 4,50,000/microL) is also elevated from Day 7-10. (Red Book 2021, AAP)

7. Osteomyelitis and Septic Arthritis

  • CRP rises within 6-12 hours; most sensitive early marker (rises before X-ray changes).
  • ESR rises within 2-3 days.
  • Serial CRP monitoring guides duration of antibiotic therapy: switch from IV to oral when CRP normalizes (< 20 mg/L), typically by Days 5-7.
  • PCT levels are generally low in non-bacteremic osteomyelitis (limited value).

8. Tuberculosis

  • ESR markedly elevated (often > 60 mm/hr); correlates with disease burden.
  • CRP elevated; normalizes with anti-TB therapy (within 2-4 months).
  • Useful for monitoring treatment response in pediatric TB.

9. Inflammatory Bowel Disease (IBD)

  • CRP and ESR elevated in active Crohn's disease and ulcerative colitis.
  • Fecal calprotectin (a direct mucosal marker) is superior to serum CRP for assessing gut inflammation.
  • PCT is typically low in IBD (despite active inflammation) - an important distinction from infection.

10. Malignancy

  • Markedly elevated CRP (> 100 mg/L) and ESR > 100 mm/hr may be the first clue to lymphoma or leukemia.
  • In ALL: leukocytosis + elevated ESR/CRP; CRP > 90 mg/L in febrile neutropenia predicts bacteremia.

LIMITATIONS AND PITFALLS

When APRs May Be Falsely Normal Despite Active Disease:

  1. SLE with active nephritis: CRP often normal; ESR markedly elevated (ESR/CRP dissociation)
  2. Pure chorea or erythema marginatum in ARF: APRs may be normal
  3. Congenital deficiencies of individual APR proteins
  4. Newborns: Lower baseline levels of many APRs; physiological PCT elevation
  5. Immunocompromised/immunosuppressed patients: Especially those on IL-6 receptor antagonists (tocilizumab, sarilumab) - CRP may be completely suppressed despite active infection

When APRs May Be Falsely Elevated (Non-inflammatory):

  1. Obesity: CRP chronically elevated (low-grade metabolic inflammation)
  2. Pregnancy
  3. Smoking
  4. Strenuous exercise
  5. Minor trauma, surgery, post-procedural state

ESR-CRP Discordance:

  • Up to 12% of hospitalized patients show discordant ESR and CRP
  • ESR high + CRP normal: SLE, renal insufficiency, transient ischemic attacks, hypergammaglobulinemia, anemia
  • CRP high + ESR normal: Early acute infection, post-myocardial infarction, after IVIG administration

HIGH-SENSITIVITY CRP (hsCRP)

A specialized assay measuring CRP at concentrations < 10 mg/L (range 0.5-10 mg/L). Used for cardiovascular risk stratification in adults. In children, emerging evidence links elevated hsCRP with:
  • Childhood obesity and metabolic syndrome
  • Kawasaki disease-related cardiovascular risk
  • Familial hypercholesterolemia
hsCRP categories for cardiovascular risk: Low risk < 1 mg/L; Average risk 1-3 mg/L; High risk > 3 mg/L

NEGATIVE ACUTE PHASE REACTANTS - CLINICAL UTILITY

Albumin:

  • Falls rapidly in acute severe illness; unreliable as nutritional marker during acute illness
  • Hypoalbuminemia in nephrotic syndrome, malnutrition, liver failure, protein-losing enteropathy
  • Serum albumin < 2.5 g/dL: significant hypoalbuminemia

Pre-albumin (Transthyretin):

  • Half-life of 2-3 days (much shorter than albumin's 21 days)
  • More sensitive and faster nutritional marker
  • Also a negative APR; falls in infection/inflammation even without malnutrition
  • Useful for monitoring nutritional repletion when inflammation has resolved

Transferrin:

  • Half-life 8-9 days
  • Negative APR + also falls in iron deficiency (misleading in mixed states)

SUMMARY TABLE: ACUTE PHASE REACTANTS AT A GLANCE

APRTypeFunctionPeak RiseKey Pediatric Use
CRPPositive (major)Opsonin, complement activationDay 2-3Infection, JIA, Kawasaki, sepsis monitoring
SAAPositive (major)Cholesterol transport, opsoninDay 2-3FMF, systemic JIA
FibrinogenPositive (moderate)CoagulationDay 2-5ESR elevation, Kawasaki
HaptoglobinPositive (moderate)Hemoglobin scavengingDay 3-5Hemolysis detection
CeruloplasminPositive (minor)Copper transport, antioxidantDay 3-5Wilson's disease (low)
Complement C3, C4Positive (minor)ImmunityDay 3-5Low in SLE (consumption)
FerritinPositive (moderate)Iron storageVariablesJIA, MAS, HLH
PCTPositive (rapid)Bacterial infection marker6-24 hoursNeonatal sepsis, UTI
AlbuminNegativeOncotic pressure, transportFalls acutelyNutritional status (limited in illness)
TransferrinNegativeIron transportFalls acutelyNutritional/iron status
Pre-albuminNegativeThyroxine, retinol transportFalls rapidlyNutritional monitoring

CONCLUSION

Acute phase reactants represent an integrated hepatic response to inflammatory stimuli, coordinated primarily by IL-6 via the JAK/STAT3 pathway. In pediatric practice, CRP remains the most clinically useful single marker owing to its rapid kinetics, wide dynamic range (up to 1000-fold), and close correlation with the degree of bacterial infection. ESR, though indirect and slow, provides complementary information especially for chronic inflammatory monitoring. Procalcitonin has emerged as the most specific early marker for systemic bacterial infection and is especially valuable in neonatal sepsis, antibiotic stewardship, and distinguishing bacterial from viral illness.
No single test is ideal for evaluating the acute phase response. Clinical judgment combined with a panel of markers - interpreted in context of the patient's age, immunological status, specific diagnosis, and treatment - yields the most accurate assessment. In children, unique considerations include physiological PCT elevation in the first 48-72 hours of life, IVIG-induced ESR elevation in Kawasaki disease, paradoxical APR dissociation in MAS/SLE, and the extreme ferritinemia of systemic JIA and HLH.

References:
  • Firestein & Kelley's Textbook of Rheumatology (Chapter 57: Acute Phase Reactants)
  • Henry's Clinical Diagnosis and Management by Laboratory Methods (Chapter: Acute-Phase Reactants, p.333)
  • Rheumatology, 2-Volume Set (Elsevier, 2022 - Chapter on Acute Phase Reactants)
  • Red Book 2021: Report of the Committee on Infectious Diseases (AAP) - Kawasaki Disease, IVIG
  • Nelson Textbook of Pediatrics (Systemic JIA, ARF, Sepsis chapters)
  • IAP Guidelines: Fever without source, Neonatal Sepsis protocols
  • Basic Medical Biochemistry - A Clinical Approach, 6th edition
  • Pediatric Infectious Diseases Society of the Philippines: APRs in Pediatric Infections (Systematic Review, 2016)
This is a shared conversation. Sign in to Orris to start your own chat.